State Street’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

State Street’s Portfolio BSX.PRA Stock Details BSX.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-174,333	Closed	-$21M	–	4792
2023 Q1	$21M	Sell	174,333 -22,287	-11%	-$2.56M	﹤0.01%	2191
2022 Q4	$22.5M	Buy	196,620 +7,087	+4%	+$781K	﹤0.01%	2162
2022 Q3	$19.4M	Buy	189,533 +25,033	+15%	+$2.65M	﹤0.01%	2253
2022 Q2	$16.7M	Sell	164,500 -9,500	-5%	-$1.04M	﹤0.01%	2381
2022 Q1	$20.3M	Sell	174,000 -26,000	-13%	-$3.01M	﹤0.01%	2392
2021 Q4	$22.9M	Buy	+200,000	New	+$22.8M	﹤0.01%	2385
2020 Q4	–	Sell	-183,000	Closed	-$20.4M	–	3918
2020 Q3	$20.4M	Sell	183,000 -17,000	-9%	-$1.91M	﹤0.01%	2031
2020 Q2	$20.9M	Buy	+200,000	New	+$21.4M	﹤0.01%	2010

Other funds holding BSX.PRA

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

State Street's BSX.PRA Position: Q2 2023 in Review

State Street sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 174,333 shares — an estimated $21M sold.

State Street first reported a position in BSX.PRA in Q2 2020 and held it in 8 quarters. The position peaked at $22.9M in Q4 2021. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

State Street reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
State Street sold 174,333 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $21M.
State Street first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 8 quarters.
State Street's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $22.9M in Q4 2021.
1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on State Street's 13F filing for Q2 2023, filed 14 Aug 2023.